Log in

688073 Bide Pharmatech Co. Ltd. SSE · China

Bide Pharmatech Co. (688073) news

Bide Pharmatech Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688073, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Bide Pharmatech Co. news

We have not published a story on Bide Pharmatech Co. yet. When there is news, it will appear here.

Questions about Bide Pharmatech Co.

What is the ticker symbol of Bide Pharmatech Co.?

Bide Pharmatech Co. Ltd. trades under the ticker 688073 on SSE.

Where is Bide Pharmatech Co. listed?

Bide Pharmatech Co. Ltd. is listed on SSE.

Which country or territory is Bide Pharmatech Co. listed under?

Our directory records Bide Pharmatech Co. Ltd. under China.

What does Bide Pharmatech Co. do?

Our directory classifies Bide Pharmatech Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Bide Pharmatech Co.?

The ISIN recorded for Bide Pharmatech Co. Ltd. is CNE100005NV3.

Does aibio.space cover Bide Pharmatech Co.?

aibio.space lists Bide Pharmatech Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Bide Pharmatech Co.?

Companies in our directory listed in the same country and business area as Bide Pharmatech Co.: Yabao Pharmaceutical Group Co., Beijing Centergate Technologies (Holding) Co., Transcenta Holding, Jiangsu Yahong Meditech Co., Hanshang Group Co., CSPC Hunan Jingfeng Pharmaceutical Co.

Investor discussion: Bide Pharmatech Co.

Members talk about Bide Pharmatech Co. (688073). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688073 on TradingView.

Listing details

Bide Pharmatech Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688073, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Bide Pharmatech Co. Ltd.
Ticker
688073
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE100005NV3
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.